Kroger Prescription Plans to Offer Myriad Genetics’ Vectra DA as Benefit Option

Kroger Prescription Plans will provide the multi-marker rheumatoid arthritis test VectraDA as a benefit option for its employer group clients.  Vectra DA gauges 12 biomarkers and measures rheumatoid arthritis disease activity. Researchers have published data showing that the test impacts doctor’s treatment recommendations, helps improve patient’s physical function, increases quality-adjusted life years, and decreases costs over 10 years.

Source: https://www.genomeweb.com/business-news/kroger-prescription-plans-offer-myriad-genetics-vectra-da-benefit-option